Key developments: mRNA vaccines and therapeutics
EPR summarises results from key mRNA vaccine trials, highlighting the future potential of these innovative therapeutics.
List view / Grid view
EPR summarises results from key mRNA vaccine trials, highlighting the future potential of these innovative therapeutics.
A study investigating the effectiveness of HPV vaccines has revealed that a single dose is as successful at preventing cervical cancer as multiple doses.
GlaxoSmithKline (GSK) has been given Chinese approval for its shingles vaccine.